Joseph Ciaffoni - 12 Feb 2024 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper as Attorney-In-Fact For Joseph Ciaffoni
Issuer symbol
COLL
Transactions as of
12 Feb 2024
Net transactions value
-$4,342,818
Form type
4
Filing time
14 Feb 2024, 16:13:23 UTC
Previous filing
22 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +119,000 +43% $0.000000 394,000 12 Feb 2024 Direct F1
transaction COLL Common Stock Award $0 +179,734 +46% $0.000000 573,734 12 Feb 2024 Direct F2
transaction COLL Common Stock Tax liability $1,598,896 -47,445 -8.3% $33.70 526,289 12 Feb 2024 Direct F3
transaction COLL Common Stock Tax liability $2,743,921 -81,422 -15% $33.70 444,867 12 Feb 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
F2 Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 179,734 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
F3 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
F4 Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.